Results 321 to 330 of about 191,378 (381)
Novel treatment strategies for cardiovascular and pulmonary diseases: Insights from cathepsin-related Mendelian randomization and Bayesian colocalization. [PDF]
Zhang C +5 more
europepmc +1 more source
ABSTRACT Background The loss of smell (anosmia) has been noted in numerous diseases, including COVID‐19. Inflammatory and microstructural alterations are possible underlying mechanisms of anosmia in COVID‐19. However, no atlas exists to study olfaction and the associated tissue property changes.
Marta Gaviraghi +17 more
wiley +1 more source
Sodium Phenylbutyrate Ameliorates Ovariectomy-Induced Bone Loss in Rats. [PDF]
Akbaş B +6 more
europepmc +1 more source
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Activity-Based Profiling of Papain-like Cysteine Proteases During Late-Stage Leaf Senescence in Barley. [PDF]
Schepetkin IA, Fischer AM.
europepmc +1 more source
Nature-Inspired Molecules as Inhibitors in Drug Discovery. [PDF]
Belluti F, Bisi A.
europepmc +1 more source
Effect of magnetic MMP removal on long‐term dentin collagen stability
Abstract Several matrix metalloproteinase (MMP) inhibitors have been investigated for their ability to improve dentin‐bond longevity. However, MMPs tend to reactivate over time, especially using simplified etch‐and‐rinse adhesives. This study investigated a novel magnetic removal of dentinal MMPs on bonding durability, MMP inhibition and collagen ...
Walter Zenobi +10 more
wiley +1 more source
SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusion. [PDF]
Magnus CL +20 more
europepmc +1 more source
We evaluated the diagnostic utility of GPNMB immunohistochemistry in LAM. GPNMB showed strong expression in LAM cells, while the differential diagnostic mimics showed no or only low expression. Based on its 100% sensitivity and specificity in our cohort, GPNMB is a highly reliable immunohistochemical marker for the diagnosis of LAM.
Fatime Szalai +6 more
wiley +1 more source
Inhibiting TRPV4 improves α-synuclein degradation through autophagy-lysosomal pathway in the MPP<sup>+</sup>-induced cell model of parkinson's disease. [PDF]
Bai Y +7 more
europepmc +1 more source

